Prognostic factors in patients with thymoma who underwent surgery
Open Access
- 11 July 2023
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 21 (1) , 1-8
Abstract
Purpose: Thymoma is the most common primary tumor in the anterior mediastinum. The prognostic factors of patients with thymoma still need to be clarified. In this study, we aimed to investigate the prognostic factors of patients with thymoma who received radical resection and establish the nomogram to predict the prognosis of these patients. Materials and methods: Patients who underwent radical resection for thymoma with complete follow-up data between 2005 and 2021 were enrolled. Their clinicopathological characteristics and treatment methods were retrospectively analyzed. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan–Meier method and compared by the log-rank test. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify the independent prognostic factors. According to the results of the univariate analysis in the Cox regression model, the predictive nomograms were created. Results: A total of 137 patients with thymoma were enrolled. With a median follow-up of 52 months, the 5-year and 10-year PFS rates were 79.5% and 68.1%, respectively. The 5-year and 10-year OS rates were 88.4% and 73.1%, respectively. Smoking status (P = 0.022) and tumor size (P = 0.039) were identified as independent prognostic factors for PFS. Multivariate analysis showed that a high level of neutrophils (P = 0.040) was independently associated with OS. The nomogram showed that the World Health Organization (WHO) histological classification contributed more to the risk of recurrence than other factors. Neutrophil count was the most important predictor of OS in patients with thymoma. Conclusion: Smoking status and tumor size are risk factors for PFS in patients with thymoma. A high level of neutrophils is an independent prognostic factor for OS. The nomograms developed in this study accurately predict PFS and OS rates at 5 and 10 years in patients with thymoma based on individual characteristics.Keywords
This publication has 31 references indexed in Scilit:
- Thymoma and thymic carcinomasCritical Reviews in Oncology/Hematology, 2016
- Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma DatabaseAnnals of Surgical Oncology, 2015
- Estimating the concordance probability in a survival analysis with a discrete number of risk groupsLifetime Data Analysis, 2015
- Modified Masaoka Stage and Size Are Independent Prognostic Predictors in Thymoma and Modified Masaoka Stage Is Superior to Histopathologic ClassificationsJournal of Thoracic Oncology, 2015
- Surgical Treatment and Prognosis of Thymic Squamous Cell Carcinoma: A Retrospective Analysis of 105 CasesThe Annals of Thoracic Surgery, 2013
- A Review of Prognostic Factors in Thymic MalignanciesJournal of Thoracic Oncology, 2011
- Prognostic Factors for Survival in Patients with Thymic Epithelial TumorsThe Thoracic and Cardiovascular Surgeon, 2011
- Epidemiology of Thymoma and Associated MalignanciesJournal of Thoracic Oncology, 2010
- Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapyEuropean Journal of Cancer, 2008
- Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravisClinical and Experimental Immunology, 2003